ETFs positioned on Sanofi

Name YTD change Weight AuM
+11.96%-.--% 24,432 M€
+3.19%-.--% 293 M€
+1.41%-.--% 51 M€
+10.37%-.--% 66 M€
+8.42%-.--% 75 M€
+10.15%-.--% 122 M€
+11.17%-.--% 67 M€
+8.58%-.--% 1,193 M€
+1.35%7.3% 391 M€
-2.48%7.24% 14 M€
+2.25%6.68% 667 M€
+1.64%6.63% 257 M€
+1.56%5.82% 49 M€
+1.31%5.82% 902 M€
+1.66%5.56% 141 M€
+4.30%5.29% 1,256 M€
+1.31%5.26% 1,024 M€
+5.03%5.26% 267 M€
-0.56%5.24% 820 M€
+4.34%4.91% 7 M€
+4.22%4.91% 3,989 M€
+12.64%4.89% 18 M€
+1.00%4.89% 331 M€
+14.31%4.82% 17 M€
+9.30%4.8% 59 M€
+7.29%4.8% 36 M€
+7.71%4.74% 252 M€
+6.53%4.47% 4 M€
+7.83%4.47% 13 M€
+14.70%4.45% 31 M€
+8.58%4.45% 31 M€
+3.11%4.23% 25 M€
-.--%4.19% 1 M€
+6.53%4.12% 4 M€
+3.50%4.01% 567 M€
+5.26%4% 9 M€
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846